Insulin Human vs Ipilimumab
Insulin Human vs Ipilimumab: Overview
This comparison examines the pharmacological differences between Insulin Human and Ipilimumab.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Insulin Human β Protein; Ipilimumab β Antibody.